{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:00:45Z","timestamp":1760551245714,"version":"3.37.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1124\/dmd.120.000187","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T02:05:13Z","timestamp":1601949913000},"page":"1364-1371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus Monkey"],"prefix":"10.1016","volume":"48","author":[{"given":"Armina","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn A.","family":"Joswig-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.120.000187_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1124\/dmd.118.085787","article-title":"Time course of aldehyde oxidase and why it is nonlinear","volume":"47","author":"Abbasi","year":"2019","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib2","doi-asserted-by":"crossref","first-page":"9469","DOI":"10.1021\/jo801053u","article-title":"Studies on the mechanism of aldehyde oxidase and xanthine oxidase","volume":"73","author":"Alfaro","year":"2008","journal-title":"J Org Chem"},{"key":"10.1124\/dmd.120.000187_bib3","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1124\/dmd.109.029520","article-title":"Purification and mechanism of human aldehyde oxidase expressed in Escherichia coli","volume":"37","author":"Alfaro","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bcp.2018.03.002","article-title":"Identification of enzymes responsible for dantrolene metabolism in the human liver: a clue to uncover the cause of liver injury","volume":"151","author":"Amano","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.120.000187_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/dmd.112.048546","article-title":"Evidence for substrate-dependent inhibition profiles for human liver aldehyde oxidase","volume":"41","author":"Barr","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib6","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1021\/mp4003046","article-title":"Absolute quantification of aldehyde oxidase protein in human liver using liquid chromatography-tandem mass spectrometry","volume":"10","author":"Barr","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.120.000187_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/03602532.2019.1667379","article-title":"Aldehyde oxidase at the crossroad of metabolism and preclinical screening","volume":"51","author":"Cheshmazar","year":"2019","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.120.000187_bib8","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1124\/dmd.113.052985","article-title":"Evaluation of rhesus monkey and guinea pig hepatic cytosol fractions as models for human aldehyde oxidase","volume":"41","author":"Choughule","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bcp.2015.05.010","article-title":"Interspecies differences in the metabolism of methotrexate: an insight into the active site differences between human and rabbit aldehyde oxidase","volume":"96","author":"Choughule","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.120.000187_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nchembio.1895","article-title":"Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase","volume":"11","author":"Coelho","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1124\/dmd.120.000187_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/00498254.2017.1296208","article-title":"A novel in vitro allometric scaling methodology for aldehyde oxidase substrates to enable selection of appropriate species for traditional allometry","volume":"48","author":"Crouch","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.120.000187_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/00498254.2012.727499","article-title":"Interspecies variation in the metabolism of zoniporide by aldehyde oxidase","volume":"43","author":"Dalvie","year":"2013","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.120.000187_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/dmd.109.030783","article-title":"Cross-species comparison of the metabolism and excretion of zoniporide: contribution of aldehyde oxidase to interspecies differences","volume":"38","author":"Dalvie","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib14","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1042\/BCJ20190532","article-title":"Toward a systems approach to cytochrome P450 ensemble: interactions of CYP2E1 with other P450 species and their impact on CYP1A2","volume":"476","author":"Davydova","year":"2019","journal-title":"Biochem J"},{"key":"10.1124\/dmd.120.000187_bib15","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.110.032375","article-title":"Species-specific metabolism of SGX523 by aldehyde oxidase and the toxicological implications","volume":"38","author":"Diamond","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0959-8049(02)00020-5","article-title":"Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration","volume":"38","author":"Dittrich","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1124\/dmd.120.000187_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/dmd.32.3.328","article-title":"An analysis of the regioselectivity of aromatic hydroxylation and N-oxygenation by cytochrome P450 enzymes","volume":"32","author":"Dowers","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib18","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.115.068395","article-title":"Optimization of the expression of human aldehyde oxidase for investigations of single-nucleotide polymorphisms","volume":"44","author":"Foti","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/dmd.109.030064","article-title":"A single amino acid substitution confers high cinchonidine oxidation activity comparable with that of rabbit to monkey aldehyde oxidase 1","volume":"38","author":"Fukiya","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1479-7364-4-2-119","article-title":"The mammalian aldehyde oxidase gene family","volume":"4","author":"Garattini","year":"2009","journal-title":"Hum Genomics"},{"key":"10.1124\/dmd.120.000187_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1517\/17425255.2012.663352","article-title":"The role of aldehyde oxidase in drug metabolism","volume":"8","author":"Garattini","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.120.000187_bib22","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1248\/bpb.30.1191","article-title":"Cloning, expression, and characterization of male cynomolgus monkey liver aldehyde oxidase","volume":"30","author":"Hoshino","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/dmd.120.000187_bib23","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1124\/dmd.114.059030","article-title":"Cynomolgus monkey as a surrogate for human aldehyde oxidase metabolism of the EGFR inhibitor BIBX1382","volume":"42","author":"Hutzler","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1517\/17425255.2013.738668","article-title":"Strategies for a comprehensive understanding of metabolism by aldehyde oxidase","volume":"9","author":"Hutzler","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.120.000187_bib25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/chir.20309","article-title":"Chiral inversion of RS-8359: a selective and reversible MAO-A inhibitor via oxido-reduction of keto-alcohol","volume":"18","author":"Itoh","year":"2006","journal-title":"Chirality"},{"key":"10.1124\/dmd.120.000187_bib26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/bdd.494","article-title":"Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase","volume":"27","author":"Itoh","year":"2006","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/dmd.120.000187_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0090-9556(24)14921-5","article-title":"Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats","volume":"27","author":"Kawashima","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bcp.2017.06.114","article-title":"Identification of enzymes responsible for nitrazepam metabolism and toxicity in human","volume":"140","author":"Konishi","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.120.000187_bib29","doi-asserted-by":"crossref","first-page":"33850","DOI":"10.1074\/jbc.M109.019125","article-title":"Characterization of the magnitude and mechanism of aldehyde oxidase-mediated nitric oxide production from nitrite","volume":"284","author":"Li","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.120.000187_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1021\/bi500987w","article-title":"Nitrite reductase activity of rat and human xanthine oxidase, xanthine dehydrogenase, and aldehyde oxidase: evaluation of their contribution to NO formation in vivo","volume":"54","author":"Maia","year":"2015","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.120.000187_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/biof.55","article-title":"Cell biology of molybdenum","volume":"35","author":"Mendel","year":"2009","journal-title":"Biofactors"},{"key":"10.1124\/dmd.120.000187_bib32","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1124\/dmd.112.046136","article-title":"The role of aldehyde oxidase and xanthine oxidase in the biotransformation of a novel negative allosteric modulator of metabotropic glutamate receptor subtype 5","volume":"40","author":"Morrison","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.120.000187_bib33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/2211-5463.12617","article-title":"Human aldehyde oxidase (hAOX1): structure determination of the Moco-free form of the natural variant G1269R and biophysical studies of single nucleotide polymorphisms","volume":"9","author":"Mota","year":"2019","journal-title":"FEBS Open Bio"},{"key":"10.1124\/dmd.120.000187_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"10.1124\/dmd.120.000187_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.abb.2018.10.017","article-title":"Substrate selectivity of human aldehyde oxidase 1 in reduction of nitroaromatic drugs","volume":"659","author":"Ogiso","year":"2018","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/dmd.120.000187_bib36","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bcp.2017.09.002","article-title":"The two faces of aldehyde oxidase: oxidative and reductive transformations of 5-nitroquinoline","volume":"145","author":"Paragas","year":"2017","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.120.000187_bib37","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1021\/acsomega.7b01054","article-title":"ecoAO: a simple system for the study of human aldehyde oxidases role in drug metabolism","volume":"2","author":"Paragas","year":"2017","journal-title":"ACS Omega"},{"key":"10.1124\/dmd.120.000187_bib38","doi-asserted-by":"crossref","first-page":"8441","DOI":"10.1021\/jm100888d","article-title":"Aldehyde oxidase: an enzyme of emerging importance in drug discovery","volume":"53","author":"Pryde","year":"2010","journal-title":"J Med Chem"},{"key":"10.1124\/dmd.120.000187_bib39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","article-title":"To scale or not to scale: the principles of dose extrapolation","volume":"157","author":"Sharma","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.120.000187_bib40","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1074\/jbc.REV119.007741","article-title":"Evolution, expression, and substrate specificities of aldehyde oxidase enzymes in eukaryotes","volume":"17","author":"Terao","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.120.000187_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.niox.2013.12.010","article-title":"Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductases","volume":"15","author":"Weidert","year":"2014","journal-title":"Nitric Oxide"},{"key":"10.1124\/dmd.120.000187_bib42","doi-asserted-by":"crossref","first-page":"107449","DOI":"10.1016\/j.pharmthera.2019.107449","article-title":"Time-dependent enzyme inactivation: numerical analyses of in vitro data and prediction of drug-drug interactions","volume":"206","author":"Yadav","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1124\/dmd.120.000187_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/tpj.2010.8","article-title":"In silico and in vitro pharmacogenetics: aldehyde oxidase rapidly metabolizes a p38 kinase inhibitor","volume":"11","author":"Zhang","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/dmd.120.000187_bib45","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1124\/dmd.110.033555","article-title":"In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase","volume":"38","author":"Zientek","year":"2010","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.120.000187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:22:33Z","timestamp":1739956953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624077596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0090955624077596"],"URL":"https:\/\/doi.org\/10.1124\/dmd.120.000187","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-Directed Mutagenesis at the Molybdenum Pterin Cofactor Site of the Human Aldehyde Oxidase: Interrogating the Kinetic Differences Between Human and Cynomolgus Monkey","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.120.000187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}